HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 26, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2022 . Quarter ended March 31, 2022 Highlights ─ compared to March 31, 2021 The quarter
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 20, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the year ended March 31, 2022 , after the close of market on Thursday, May 26, 2022 . The release will be accessible on Taro’s
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Feb. 28, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) today announced the completion of its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma. The acquisition includes Alchemee’s business and assets worldwide,
Alchemee’s flagship brand Proactiv® is an iconic product synonymous with acne care ZUG, Switzerland & HAWTHORNE, N.Y. --(BUSINESS WIRE)--Feb. 22, 2022-- Galderma and Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced today they have signed a definitive agreement for Taro to acquire
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 27, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2021 . Quarter ended December 31, 2021 Highlights ─ compared to December 31,
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Jan. 20, 2022-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 2021 , after the close of market on Thursday, January 27, 2022 .
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Dec. 1, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) today announced the appointment of William J. Coote as Vice President, Chief Financial Officer and Chief Accounting Officer, effective today. Mr.
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 28, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and six months ended September 30, 2021 . Quarter ended September 30, 2021 Highlights ─ compared to September 30,
HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 21, 2021-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2021 , after the close of market on Thursday, October 28, 2021 .
Alerts are e-mailed to you whenever certain new company information is posted to this site.
